Cohance Lifesciences Limited
COHANCE
Peringkat dalam Saham
#6337
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Harga Saham
$5.09
Kapitalisasi Pasar
$1.95B
Perubahan (1 hari)
0.79%
Perubahan (1 tahun)
-57.04%
Negara
IN
Perdagangan Cohance Lifesciences Limited (COHANCE)
Kategori
Healthcare
Rasio P/B untuk Cohance Lifesciences Limited (COHANCE)
Rasio P/B per October 2026 TTM: 22.54
Menurut laporan keuangan dan harga saham terbaru dari Cohance Lifesciences Limited, rasio P/B saat ini (TTM) adalah 22.54. Pada akhir 2024, rasio P/B perusahaan adalah 8.31.
Riwayat rasio P/B untuk Cohance Lifesciences Limited dari 2019 hingga 2026
Rasio P/B pada akhir setiap tahun
| Tahun | Rasio P/B | Mengubah |
|---|---|---|
| 2026 (TTM) | 22.54 | 41.50% |
| 2025 | 15.93 | 91.72% |
| 2024 | 8.31 | 19.91% |
| 2023 | 6.93 | -32.77% |
| 2022 | 10.31 | -3.75% |
| 2021 | 10.71 | 253.56% |
| 2020 | 3.03 | -58.32% |
| 2019 | 7.27 | 0.00% |
Rasio P/B untuk perusahaan sejenis atau pesaing
| Perusahaan | Rasio P/B | Perbedaan Rasio P/B | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -77.64% |
IN
|
